1373PIdentification of subjects with locally advanced lung cancer who are likely to respond to standard-of-care chemoradiotherapy by a longitudinal monitoring of circulating tumor DNA (ctDNA) using a comprehensive ultra-sensitive NGS assay. (23rd October 2018) - Vitazka, P; Tikoo, N; Balasubramanyam, A; Xi, L; Yaung, S; Kwok, E; Lovejoy, A; Klass, D; Heibeck, M; Probst, K; Rehfeldt, A; Meldgaard, E; et al.